Skip to main content
UnicornBurnBETA
Evaluate a dealFeaturesMethodologyPricing
// sign inStart free →
Evaluate a dealFeaturesMethodologyPricing// sign inStart free trial →

// PLATFORM

FeaturesEvaluate a dealMethodologyPricingAPI

// COMPANY

AboutChangelogSecurityContact

// EXPLORE

AutopsiesRankingsInvestorsShare your story
© 2026 UnicornBurn
PrivacyTermsData RightsAccessibility
← All autopsies·Colombia·Healthtech
// startup autopsy

Nexura

Telemedicine platform for Colombia. COVID arrived — but so did every other telemedicine startup.

timing
Founded2017
Closed2020
CountryColombia
SectorHealthtech
Raised$2M
FounderAlejandra Gómez

// the model, blind

Evaluating only Nexura’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Market timing.

Full Analysis

Free · no account needed

Documented cause

Nexura built a telemedicine platform connecting Colombian patients with specialist doctors. It had 50 clinic partnerships when COVID-19 hit in March 2020. The pandemic initially seemed like a tailwind — telemedicine demand exploded. But well-funded competitors including Doctoralia, Doctoranytime, and hospital-backed platforms entered the market simultaneously with COVID-era capital. Nexura could not compete for physician supply or patient acquisition against better-capitalized entrants.

Lesson

“A pandemic tailwind attracts well-funded competition as fast as it creates demand. If you're the underfunded incumbent when the tailwind hits, you get flooded, not lifted. Raise ahead of the macro event, not during it.”

FAQ

Why did Nexura fail?

Nexura, a Colombian telemedicine platform with 50 clinic partners, failed in 2020 despite COVID-era demand surge. Well-funded competitors flooded the market simultaneously, and Nexura could not compete for physician supply or patient acquisition.

// MORE HEALTHTECH FAILURES
Outcome Health
Healthtech
compare →
Limeade Israel
Healthtech
compare →
FitPal Mexico
Healthtech
compare →
Medicinas Online
Healthtech
Regulatory Kill
compare →
// engine intelligence on Nexura
Tier 1 · instant unlock🔒 free account
Loading engine analysis…
Tier 2 · the productAnalyst · €149/mo

What you see retrospectively on Nexura, applied predictively to your companies:

  • →Cross-reference this pattern against your live portfolio
  • →Alerts when a company you track starts matching this profile
  • →Export the IC-ready risk brief (PDF)
See Analyst plan →Evaluate a deal →

5,032 documented autopsies · 85.9% Top-3 cause match. How we measure accuracy →

← PrevReworthFintechNext →FinkargoFintech
XLinkedInClaim this autopsy·Report error
¿Te ha sido útil?